Volume 2, Issue 1

• Valproic Acid-Associated Neurologic Syndrome in Chronic Mental Illness:A Case Report
  Author(s): David I. Mayerhoff , Steven J. Schleifer , Jeffry R. Nurenberg
  • Abstract
  • PDF
• Drug Treatment of Depressive Symptoms in Schizophrenia
  Author(s): Hans-Jürgen Möller
  • Abstract
  • PDF
• Neural Effects of Ziprasidone Monotherapy in First-Episode Schizophrenia: A Longitudinal Study using fMRI and a Procedural Learning Paradigm
  Author(s): Veena Kumari , Anantha P. P. Anilkumar , Dominic H. ffytche ,Ravi Mehrotra , Martina T. Mitterschiffthaler , Tonmoy Sharma
  • Abstract
  • PDF
• Cognitive Improvement of Schizophrenia Patients: Enhancing Cognition while Enjoying Computer-Aided Cognitive Training
  Author(s): Wolfgang Trapp , Alexander Hasmann , Bernd Gallhofer ,Johannes Schwerdtner , Wilfried Guenther , Matthias Dobmeier
  • Abstract
  • PDF
• All Psychotic Roads Lead to Increased Dopamine D2High Receptors: A Perspective
  Author(s): Philip Seeman
  • Abstract
  • PDF
• Update from the ACNP Meeting Williams Syndrome �??Schizophrenia in Reverse?
  Author(s): Robert R. Conley
  • Abstract
  • PDF
• Aripiprazole in Addition to Clozapine in Partially Responsive Patients with Schizophrenia: A Critical Review of Case Series
  Author(s): Serena Mulè , Andrea Cipriani , Corrado Barbui
  • Abstract
  • PDF